The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma

American Journal of Gastroenterology

Volumn 91, Issue 6, 1996, Pages 1195-1203

  Chiba, Toshiya ^b   Matsuzaki, Yasushi ^b   Abei, Masato ^b   Shoda, Junichi ^b   Tanaka, Naomi ^b   Osuga, Toshiaki ^b   Aikawa, Tatsuya ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; CANCER RISK; CHRONIC LIVER DISEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; VIRUS CARCINOGENESIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS C; HUMANS; JAPAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 0029947938     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Munoz N, Bosch EX. Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the liver. Tokyo: Springer-Verlag, 1987:3-19.
2. Linsell DA, Hibbinson J. The geographic pathology of liver cell cancer. In: Cameron HM, Linsell DA, Warwick GP, eds. Liver cell cancer. New York; Elsevier, 1976:1-16.
3. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma epidemiologic considerations. Hepatology 1982;2(suppl): 21-6.
4. Kew M, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984;4:136-46.
5. Beasley RP, Hwang LY. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 1984;4:113-21.
6. Sakuma K, Saitoh N, Kasai M, et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: A prospective study. Hepatology 1988;8:1642-6.
7. Seifer M, Hoehne M, Schaefer S, et al. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. J Hepatol 1991;13:61-5.
8. Kim CM, Koike K, Saito I, et al. HBx gene of hepatitis B virus induced liver cancer in transgenic mice. Nature 1991;351:317-20.
9. Natoli G, Avantaggiati ML, Balsano C, et al. Characterization of hepatitis B virus preS/S region encoded transcriptional transactivator. Virology 1992;187:663-70.
10. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
11. Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
12. Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2:1004-6.
13. Colombo M, Kuo G, Choo Q-L, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;2:1006-8.
14. Yu MC, Tong AJ, Cousaget P, et al. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990;82:1038-41.
15. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
16. Nishioka K, Watanabe J, Furuta S, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67:429-33.
17. Tanaka K, Hirohata T, Koga S, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-7.
18. Resnick RH, Koff R. Hepatitis C-related hepatocellular carcinoma, prevalence and significance. Arch Intern Med 1993;153:1672-7.
19. Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: Report 8. Acta Hepatol Jpn 1988;29: 1619-26 (in Japanese).
20. Ohnishi K, Iida S, Iwama S, Goto N, et al. The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: Relation to hepatitis B surface antigen carriage. Cancer 1982;49:672-7.
21. Oshima A, Tsukuma H, Hiyama T, et al. Follow-up study of HBsAg-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer 1984;34:775-9.
22. Okamoto H, Munekata E, Tsuda F, et al. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide. Jpn J Exp Med 1990;60:223-3.
23. Okamoto H, Tsuda F, Machida A, et al. Antibodies against synthetic oligopeptide deduced from the putative core gene for the diagnosis of hepatitis C virus infection. Hepatology 1992;15:180-6.
24. Mishiro S, Hoshi Y, Takeda K, et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: Implication for an autoimmune process. Lancet 1990;336:1400-3.
25. Saito M, Hasegawa A, Kashiwakuma T, et al. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new agents (c11/c7). Clin Chem 1992;38:2434-9.
26. Harrington DP, Fleming TR. A class of rank test procedures for censored survival data. Biometrica 1982;69:553-66.
27. Cox DR. Regression models and life tables. J R Stat Soc 1972;34: 187-220.
28. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457-81.
29. Yano M, Yatsuhashi H, Inoue O, et al. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 1993;(suppl): S13-6.
30. Tanaka N, Chiba T, Matsuzaki Y, et al. High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma. Gastroenterol Jpn 1993;28:547-53.
31. Hino O, Shows T, Rogler CE. Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17; 18 translocation. Proc Natl Acad Sci USA 1986;83:8338-42.
32. Fourel G, Trepo C, Bougueleret L, et al. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors. Nature 1990;347:294-8.
33. Zhou YZ, Slagle BL, Donehower LA, et al. Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol 1988;62:4224-31.
34. Chisari FV, Klopchin K, Moriyama T, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989;59:1145-56.
35. Kalayci C, Johnson PJ, Davies SE, et al. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol 1991; 12:54-9.
36. Trichopoulos D, MacMahon B, Sparros L, et al. Smoking and hepatitis B-negative primary hepatocellular carcinoma. J Natl Cancer Inst 1980; 65:111-4.
37. Hirayama T. A large-scale cohort study on the relationship between diet and selected cancers of digestive organs. In: Bruce WR, Correa P, Lipkin M, et al., eds. Gastrointestinal cancer: Endogenous factors. Banbury report 7. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1981:409-26.
38. Shibata A, Hirohata T, Toshima H, et al. The role of drinking and cigarette smoking in the excess deaths from liver cancer. Jpn J Cancer Res 1986;77:287-95.
39. Simonetti RG, Cammá C, Fiorello F, et al. Hepatocellular carcinoma: A worldwide problem and major risk factors. Dig Dis Sci 1991;36: 962-72.
40. Galloway DA, McDougall JK. The oncogenic potential of herpes simplex viruses: Evidence for a "hit and run" mechanism. Nature 1983;302:21-4.
41. Paterlini P, Gerken G, Nakajima E, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80-5.
42. Kaneko S, Miller RH, Feinstone SM, et al. Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chin reaction assay. Proc Natl Acad Sci USA 1989;86:312-6.
43. Liang TJ, Baruch Y, Ben-Porath E, et al. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991;13:1044-51.
44. Luo KX, Zhou R, He C, et al. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 1991;35:55-9.
45. Sheu J-C, Huang G-T, Shih L-N, et al. Hepatitis C and B virus in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103:1322-7.
46. Ruiz J, Sangro B, Cuende JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992;16:637-41.
47. Paterlini P, Driss F, Nalpas B, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: A study of a low-endemic area. Hepatology 1993; 17:20-9.
48. Zhang YY, Hansson BG, Kuo LS, et al. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 1993;17:538-44.
49. Yu M-W, You S-L, Chang A-S, et al. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5.
50. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-801.
51. Yen S, Hsieh C-C, MacMahon B. Consumption of alcohol and tobacco and other risk factors for pancreatitis. Am J Epidemiol 1982;116:407-14.
52. Mack TM, Yu MC, Hanisch R, et al. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986;76:49-60.
53. Schulze J, Richter E, Binder U, et al. Biliary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the rat. Carinogenesis 1992;13:1961-5.
54. Takada A, Nei J, Takase S, et al. Effect of ethanol on experimental hepatocarcinogenesis. Hepatology 1986;6:65-72.
55. Villa E, Rubbiani L, Barchi T, et al. Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage. Lancet 1982;ii:1243-4.
56. Murata T, Takanari H, Watanabe S, et al. Enhancement of chronic viral hepatitic changes by alcohol intake in patients with persistent HBs-antigenemia. Am J Clin Pathol 1990;94:270-3.
57. Yamauchi M, Nakahara M, Maezawa Y, et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993;88:39-43.
58. Zaaijer HL, Cuypers HT, Reesink HW, et al. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341: 722-4.
59. Lok ASF, Cheung R, Chan R, et al. Hepatitis C viremia in patients with hepatitis C virus infection. Hepatology 1992;15:1007-12.
60. Chemello L, Cavalletto D, Pontisso P, et al. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology 1993;17:179-82.